Extremely low frequency magnetic fields inhibit adipogenesis of human mesenchymal stem cells

Bioelectromagnetics

Volumn 35, Issue 7, 2014, Pages 519-530

  Du, Leilei ^a   Fan, Hongye ^a   Miao, Huishuang ^a   Zhao, Guangfeng ^a   Hou, Yayi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Adipogenic differentiation; ELF MF; MSCs; Obesity; PPAR 2

Indexed keywords

CELL CULTURE; ELECTROMAGNETIC FIELDS; FLOWCHARTING; MAGNETIC FIELDS; NUTRITION; STEM CELLS;

ADIPOCYTES; ADIPOGENIC DIFFERENTIATIONS; CELL-BE; CELL/B.E; CELL/BE; EXTREMELY LOW FREQUENCY MAGNETIC FIELDS; INHIBITORY EFFECT; MESENCHYMAL STEM CELL; OBESITY; PPARΓ2;

CELL DEATH;

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STRESS ACTIVATED PROTEIN KINASE;

ADIPOGENESIS; ADVERSE EFFECTS; APOPTOSIS; BONE DEVELOPMENT; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MAGNETIC FIELD; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; RADIATION RESPONSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ADIPOGENESIS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAGNETIC FIELDS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL CORD; WNT SIGNALING PATHWAY;

EID: 84908870006     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.21873     Document Type: Article

References (52)

1. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. 2004. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855.
2. Attie AD, Scherer PE. 2009. Adipocyte metabolism and obesity. J Lipid Res 50:S395-399.
3. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPAR g is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585-595.
4. Bassett CA. 1982. Claims for magnetotherapy. Can Med Assoc J 127:1079-1080.
5. Bassett CA, Mitchell SN, Gaston SR. 1981. Treatment of ununited tibial diaphyseal fractures with pulsing electromagnetic fields. J Bone Joint Surg Am 63:511-523.
6. Beilin G, Benech P, Courie R, Benichoux F. 2012. Electromagnetic fields applied to the reduction of abdominal obesity. J Cosmet Laser Ther 14:24-42.
7. Bilkovski R, Schulte DM, Oberhauser F, Gomolka M, Udelhoven M, Hettich MM, Roth B, Heidenreich A, Gutschow C, Krone W, Laudes M. 2010. Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes. J Biol Chem 285:6170-6178.
8. Bilkovski R, Schulte DM, Oberhauser F, Gomolka M, Udelhoven M, Hettich MM, Roth B, Heidenreich A, Gutschow C, Krone W, Laudes M. 2010. Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes. J Biol Chem 285:6170-6178.
9. Bowers RR, Lane MD. 2007. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 6:385-389.
10. Brighton CT. 1984. The semi-invasive method of treating nonunion with direct current. Orthop Clin North Am 15:33-45.
11. Ceccarelli G, Bloise N, Mantelli M, Gastaldi G, Fassina L, De Angelis MGC, Ferrari D, Imbriani M, Visai L. 2013. A comparative analysis of the in vitro effects of pulsed electromagnetic field treatment on osteogenic differentiation of two different mesenchymal cell lineages. Biores Open Access 2:283-294.
12. Church V, Nohno T, Linker C, Marcelle C, Francis-West P. 2002. Wnt regulation of chondrocyte differentiation. J Cell Sci 115:4809-4818.
13. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. 2008. The metabolic syndrome. Endocr Rev 29:777-822.
14. Creecy CM, O'Neill CF, Arulanandam BP, Sylvia VL, Navara CS, Bizios R. 2013. Mesenchymal stem cell osteodifferentiation in response to alternating electric current. Tissue Eng Part A 19:467-474.
15. Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Cell 8:739-750.
16. Esposito M, Lucariello A, Costanzo C, Fiumarella A, Giannini A, Riccardi G, Riccion I. 2013. Differentiation of human umbilical cord-derived mesenchymal stem cells, WJ-MSCs, into chondrogenic cells in the presence of pulsed electromagnetic fields. In Vivo 27:495-500.
17. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. 2004. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860.
18. Friedman JM. 2004. Modern science versus the stigma of obesity. Nat Med 10:563-569.
19. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME. 2006. Playing with bone and fat. J Cell Biochem 98:251-266.
20. Glimcher LH, Jones DC, Wein MN. 2007. Control of postnatal bone mass by the zinc finger adapter protein Schnurri-3. Ann NYAcad Sci 1116:174-181.
21. Hasegawa S, Yamasaki M, Inage T, Takahashi N, Fukui T. 2008. Transcriptional regulation of ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, by C/EBPalpha during adipocyte differentiation. Biochim Biophys Acta 1779:414-419.
22. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992. Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
23. He S, Pant D, Schiffmacher A, Meece A, Keefer CL. 2008. Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 26:842-849.
24. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
25. Holleville N, Matéos S, Bontoux M, Bollerot K, Monsoro-Burq AH. 2007. Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme. Dev Biol. 304:860-874.
26. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO. 2005. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280:21162-21168.
27. Kersten S, Desvergne B, Wahli W. 2000. Roles of PPARs in health and disease. Nature 405:421-424.
28. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kadowaki T. 1999. PPAR g mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609.
29. Lefterova MI, Lazar MA. 2009. New developments in adipogenesis. Trends Endocrinol Metab 20:107-114.
30. Ling L, Nurcombe V, Cool SM. 2009. Wnt signaling controls the fate of mesenchymal stem cells. Gene 433:1-7.
31. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
32. Mayer-Wagner S, Passberger A, Sievers B, Aigner J, Summer B, Schiergens TS, Jansson V, Müller PE. 2011. Effects of low frequency electromagnetic fields on the chondrogenic differentiation of human mesenchymal stem cells. Bioelectromagnetics 32:283-290.
33. Nichols TW, Jr. 2012. Mitochondria of mice and men: Moderate magnetic fields in obesity and fatty liver. Med Hypotheses 79:287-293.
34. Nie Y, Du L, Mou Y, Xu Z, Weng L, Du Y, Zhu Y, Hou Y, Wang T. 2013. Effect of low frequency magnetic fields on melanoma:Tumor inhibition and immune modulation. BMC Cancer 13:582.
35. Noer A, Boquest AC, Collas P. 2007. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol 8:18.
36. Pi-Sunyer X. 2009. The medical risks of obesity. Postgrad Med 121:21-33.
37. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
38. Rao TP, Kühl M. 2010. An updated overview on Wnt signaling pathways: A prelude for more. Circ Res 106:1798-1806.
39. Rosen E, Eguchi J, Xu Z. 2009. Transcriptional targets in adipocyte biology. Expert Opin Ther Targets 13:975-986.
40. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. 1999. PPAR g is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617.
41. Rosen ED, Spiegelman BM. 2001. PPARg: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 12:37731-37734.
42. Rubin CT, McLeod KJ, Lanyon LE. 1989. Prevention of osteoporosis by pulsed electromagnetic fields. J Bone Joint Surg Am 71:411-417.
43. Schwartz Z, Simon BJ, Duran MA, Barabino G, Chaudhri R, Boyan BD. 2008. Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells. J Orthop Res 26:1250-1255.
44. Skerry TM, Pead MJ, Lanyon LE. 1991. Modulation of bone loss during disuse by pulsed electromagnetic fields. J Orthop Res 9:600-608.
45. Taipaleenmaki H, Abdallah BM, Al Dahmash A, Saamanen AM, Kassem M. 2011. Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 317:745-756.
46. Takeda S, Elefteriou F, Karsenty G. 2003. Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr 23:403-411.
47. Tchoukalova Y, Koutsari C, Jensen M. 2007. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 50:151-157.
48. Tominaga S, Yamaguchi T, Takahashi S, Hirose F, Osumi T. 2005. Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase. Biochem Biophys Res Commun 326:499-504.
49. Tong Z, Duncan RL, Jia X. 2013. Modulating the behaviors of mesenchymal stem cells via the combination of highfrequency vibratory stimulations and fibrous scaffolds. Tissue Eng Part A 19:1862-1878.
50. Tontonoz P, Hu E, Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPAR g 2, a lipid-activated transcription factor. Cell 79:1147-1156.
51. Wang T, Nie Y, Zhao S, Han Y, Du Y, Hou Y. 2011. Involvement of midkine expression in the inhibitory effects of lowfrequency magnetic fields on cancer cells. Bioelectromagnetics 32:443-452.
52. Yang Y, Tao C, Zhao D, Li F, Zhao W, Wu H. 2010. EMF acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Bioelectromagnetics 31:277-285.